HDAC3 modulates cancer immunity via increasing PD-L1 expression in pancreatic cancer

Published 2019 View Full Article

Authors

Keywords

Programmed death ligand 1 (PD-L1), Histone deacetylase 3 (HDAC3), Signal transducer and activator of transcription 3 (STAT3), Cancer immunity, Pancreatic ductal adenocarcinoma (PDAC)

Journal

PANCREATOLOGY

Volume -, Issue -, Pages -

Publisher

Elsevier BV

Online

2019-01-17

DOI

10.1016/j.pan.2019.01.011

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started